- •Some platelet-activating HIT antibodies may not induce serotonin release in the SRA.
- •The PEA detected SRA-negative antibodies in the two HIT patients described
- •Recognition of “SRA-negative HIT” is important for appropriate patient management.
Purchase one-time access:Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
One-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
- How I diagnose and manage HIT.Hematology Am. Soc. Hematol. Educ. Program. 2011; 2011: 143-149
- A diagnostic test for heparin-induced thrombocytopenia.Blood. 1986; 67: 27-30
- Beneficial effect of exogenous platelet factor 4 for detecting pathogenic heparin-induced thrombocytopenia antibodies.Br. J. Haematol. 2017; 179: 811-819
- A novel PF4-dependent platelet activation assay identifies patients likely to have heparin-induced thrombocytopenia/thrombosis.Chest. 2016; 150: 506-515
- A platelet factor 4-dependent platelet activation assay facilitates early detection of pathogenic heparin-induced thrombocytopenia antibodies.Chest. 2017; 152: e77-e80
- Improving the specificity of the PF4 ELISA in diagnosing heparin-induced thrombocytopenia.Am. J. Hematol. 2012; 87: 776-781
- Functional assays in the diagnosis of heparin-induced thrombocytopenia: a review.Molecules. 2017; 22
- Heparin-induced thrombocytopenia in a cardiac surgery patient with early and persistent thrombocytopenia and initial negative immunological and functional assays.Thromb. Res. 2018; 169: 93-95
- Distinguishing between anti-PF4/heparin antibodies that can and cannot cause heparin-induced thrombocytopenia.J. Thromb. Haemost. 2015; 13: 1900-1907